Showing results (521-530 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|January 17, 2017
Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trialIsabel Garcia-Perez, Joram M Posma, Rachel Gibson, et al.
The Lancet. Diabetes & Endocrinology|October 17, 2016
Influence of maternal obesity on the long-term health of offspringKeith M Godfrey, Rebecca M Reynolds, Susan L Prescott, et al.
The Lancet. Diabetes & Endocrinology|October 6, 2022
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registriesNiels H Birkebaek, Clemens Kamrath, Julia M Grimsmann, et al.
The Lancet. Diabetes & Endocrinology|September 4, 2022
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled studyPratik Choudhary, Ralf Kolassa, Winfried Keuthage, et al.
The Lancet. Diabetes & Endocrinology|August 7, 2019
Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort studyJérémie Thereaux, Thomas Lesuffleur, Sébastien Czernichow, et al.
The Lancet. Diabetes & Endocrinology|August 19, 2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
The Lancet. Diabetes & Endocrinology|December 19, 2021
Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemiaGary F Lewis, Robert A Hegele
The Lancet. Diabetes & Endocrinology|March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trialAneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
New insights into cystic fibrosis-related diabetes in childrenKatie L Ode, Antoinette Moran
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
Pageof 93